Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in drugs

US FDA Warns Sri Krishna Pharma, Citing Drug-data Manipulation

Sri Krishna Pharmaceuticals, a supplier of paracetamol and other drugs to more than 60 countries, has been warned by the US Food and Drug Administration, which cited manipulation of its test results at a plant

Read More

Two Indian Generics Makers End Battle To Copy Drugs Amid Patent Debate

Two Indian drugmakers said they had given up a battle to copy drugs developed by Bristol Myers Squibb and AstraZeneca , blaming a lack of government support for cheap generics and pressure from Big Pharma

Read More

Pfizer, Allergan Scrap $160 Billion Deal After US Tax Rule Change

US drugmaker Pfizer Inc and Ireland-based Allergan Plc walked away from their $160 billion merger on Wednesday, a major win for President Barack Obama, who has been pushing to curb deals in which companies move overseas to save on taxes

Read More

Lupin Says It Sees No Supply Disruption At Plant Despite FDA Observations

The company said it did not expect any disruption to supply from its main manufacturing plant despite what it called minor observations made by the US Food and Drug Administration after an audit

Read More

Cadila's Shares Fall After WHO Faults Vaccines Plant Standards

Cadila Healthcare's shares fell on Wednesday after the World Health Organization cited violations of manufacturing and clinical standards at one of the drugmaker's vaccines factory in Gujarat

Read More

Delhi High Court Extends Relief To Pharma Firms In Drug Ban Case

The Delhi High Court restrained the government from enforcing a ban on hundreds of drugs for another week on Monday until it has heard petitions from drugmakers challenging the order

Read More

Drugs Ban | Partial Relief From High Court For Wockhardt, Glaxo And Griffon

The drugs which were subject matter of today's plea are Aceproxyvon, Viscodyne and Viscodyne-D of Wockhardt, Crocin Cold and Flu Max of Glaxo and Grilinctus syrup of Griffon.

Read More

Emcure Pharma Gets US FDA Warning Letter; Indian Drug Industry Vows For Quality Excellence

The US Food and Drug Administration has warned Indian generic drugmaker Emcure Pharmaceuticals, saying it repeatedly fudged test records at its plant at Pune

Read More

US Industry Body Says India Agreed To Not Issue 'Compulsory' Drug Licences

India has given private assurances that it will not grant licences allowing local firms to override patents and make cheap copies of drugs by big Western drugmakers, a US business advocacy group said

Read More

US, EU Regulators Urge Indian Drug Companies To Step Up Standards

India supplies about 33 per cent of the medicines sold in the United States, and nearly a quarter sold in the UK

Read More

Cipla Completes $550 Million Acquisition Of Two US Firms

With this acquisition, pharmaceutical firm Cipla will have more relevance to wholesale and retail customers

Read More

Sun Pharma Q3 Profit Beats Street, To Wind Down JV With Merck

The company posts net earnings for the quarter ended December 31 of Rs 1,417 crore, compared with Rs 1,425 crore a year earlier

Read More

Cipla's Q3 Profit Hurt By One-off Charge

The company posted a net profit of Rs 343 crore for the quarter ended December 31, slightly above the Rs 328 crore reported a year earlier

Read More

2015 Marks Mixed Trend For Pharma Sector

The Rs 1,50,000 crore worth drugs pharmaceuticals industry is currently one of the most robust sectors in India

Read More

USFDA Gives Dr Reddy’s Extra Time To Respond To Warning Letter

Dr Reddy’s Laboratories Ltd on Thursday said the USFDA has extended the time-frame for replying to the warning letter issued to the company by about two weeks to December 7

Read More